Diversified Healthcare Trust (NASDAQ:DHC) Trading Up 9.4% – What’s Next?

Diversified Healthcare Trust (NASDAQ:DHC) shares rose 9.4% during trading on Monday . The company traded as high as $2.44 and last traded at $2.38. Approximately 560,831 shares were traded during trading, a decline of 35% from the average daily volume of 860,521 shares. The stock had previously closed at $2.17.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on DHC shares. Royal Bank of Canada raised their target price on Diversified Healthcare Trust from $2.00 to $3.00 and gave the company an “underperform” rating in a research report on Monday, October 14th. StockNews.com downgraded shares of Diversified Healthcare Trust from a “hold” rating to a “sell” rating in a research report on Monday, January 6th.

Diversified Healthcare Trust Stock Up 9.4 %

The company has a fifty day moving average price of $2.33 and a 200 day moving average price of $3.02. The company has a market cap of $573.02 million, a PE ratio of -1.47 and a beta of 2.17. The company has a debt-to-equity ratio of 1.44, a current ratio of 11.57 and a quick ratio of 11.57.

Diversified Healthcare Trust (NASDAQ:DHC) last posted its quarterly earnings data on Monday, November 4th. The real estate investment trust reported ($0.41) earnings per share for the quarter, missing the consensus estimate of $0.05 by ($0.46). Diversified Healthcare Trust had a negative net margin of 26.09% and a negative return on equity of 17.55%. The company had revenue of $373.64 million for the quarter, compared to analysts’ expectations of $376.80 million. During the same quarter last year, the business posted $0.03 EPS.

Diversified Healthcare Trust Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, February 20th. Investors of record on Monday, January 27th will be given a dividend of $0.01 per share. The ex-dividend date of this dividend is Monday, January 27th. This represents a $0.04 annualized dividend and a yield of 1.68%. Diversified Healthcare Trust’s payout ratio is -2.48%.

Institutional Investors Weigh In On Diversified Healthcare Trust

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. XTX Topco Ltd bought a new position in shares of Diversified Healthcare Trust during the second quarter valued at approximately $74,000. AQR Capital Management LLC boosted its holdings in shares of Diversified Healthcare Trust by 128.3% during the 2nd quarter. AQR Capital Management LLC now owns 166,215 shares of the real estate investment trust’s stock valued at $507,000 after buying an additional 93,421 shares in the last quarter. Deerfield Management Company L.P. Series C grew its position in shares of Diversified Healthcare Trust by 4.8% in the 2nd quarter. Deerfield Management Company L.P. Series C now owns 88,223 shares of the real estate investment trust’s stock worth $269,000 after buying an additional 4,055 shares during the period. Algert Global LLC increased its stake in shares of Diversified Healthcare Trust by 3.0% in the 2nd quarter. Algert Global LLC now owns 307,915 shares of the real estate investment trust’s stock worth $939,000 after acquiring an additional 8,878 shares in the last quarter. Finally, SG Americas Securities LLC boosted its stake in Diversified Healthcare Trust by 82.1% during the third quarter. SG Americas Securities LLC now owns 75,293 shares of the real estate investment trust’s stock worth $315,000 after acquiring an additional 33,942 shares in the last quarter. 75.98% of the stock is currently owned by institutional investors.

Diversified Healthcare Trust Company Profile

Diversified Healthcare Trust is a real estate investment trust, which engages in the ownership of senior living communities, medical office buildings, and wellness centers. It operates through the following segments: Office Portfolio, Senior Housing Operating Portfolio (SHOP), and Non-Segment. The Office Portfolio segment consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties leased to biotech laboratories and other similar tenants.